Search Results for: Check Point

$5 million grant to test Alzheimer’s treatment

Posted on December 26, 2021

Israel’s ImmunoBrain Checkpoint (see here previously) has been awarded a grant of $5 million over 3 years to support human clinical trials of IBC-Ab002, for the treatment of Alzheimer’s disease. Development was based on Weizmann Institute immune system studies. https://www.weizmann-usa.org/news-media/in-the-news/immunobrain-checkpoint-awarded-5-million-us-nia-grant-for-phase-1b-alzheimer-s-disease/

Posted in Israel's Medical Achievements | Leave a comment

The impact of the microbiome on cancer

Posted on April 18, 2021

Israel’s MyBiotics (see here previously) is to partner Hadasit – the technology transfer arm of Hadassah Medical Center, to identify gut microbiome-based cancer therapies. They will study up to 100 melanoma patients treated with PD-1/PD-L1 checkpoint inhibitor immunotherapies. https://www.timesofisrael.com/mybiotics-hadassah-to-study-impact-of-microbiome-on-cancer-therapies/

Posted in Israel's Medical Achievements | Leave a comment

Safer remote access

Posted on September 23, 2020

Israeli startup Odo Security has developed a new, cloud-based technology that can be deployed in five minutes via the Cloud to provide employees working from home with secure access to their company’s systems. Odo has just been acquired by Israeli … Continue reading →

Posted in Science & Technology | Leave a comment

Antibody for Alzheimer’s

Posted on September 13, 2020

Israel’s ImmunoBrain Checkpoint aims to begin trials of its IBC-Ab002 treatment for Alzheimer’s disease. The antibody, developed by its Chief Scientist EMET Prize-winning Weizmann Institute Professor Michal Schwartz, boosts the immune system to induce brain repair processes. https://www.jpost.com/health-science/israeli-revolutionary-alzheimers-treatment-to-launch-phase-1-trial-641848 https://www.ibcheckpoint.com/

Posted in Israel's Medical Achievements | Leave a comment

Another good trial of colon capsule scan

Posted on February 2, 2020

Israel’s Check-Cap has announced positive results from its latest US pilot study of its C-Scan colon capsule system. The dual-center study achieved both primary (safety) and secondary (patient satisfaction and performance) endpoints. C-Scan is already CE approved. http://ir.check-cap.com/2019-12-30-Check-Cap-Announces-Positive-Results-from-U-S-Pilot-Study-of-C-Scan-R-System

Posted in Israel's Medical Achievements | Leave a comment

More Palestinian Arabs work in Israel

Posted on October 1, 2019

The number of Palestinian Arabs working in Israel has almost doubled in the past five years.  The number of permits for employment in Israel had risen 160% since 2012.  Waiting times at checkpoints between the territories and Israel have been … Continue reading →

Posted in Israel is Inclusive & Global | Leave a comment

Chabad care for IDF in Hebron

Posted on January 14, 2019

The Chabad organization is well known for caring for Jews globally, but it also works in Israel. Rabbi Cohen and the students of Hebron Chabad visit every local IDF outpost, checkpoint and base before Shabbat and Jewish holidays to support … Continue reading →

Posted in The Jewish State | Leave a comment

Double security award

Posted on July 16, 2017

Israel’s Dome9 Security (mentioned here in Jan 2012) has won “Best Cloud Security Product” in the 2017 Cybersecurity Excellence Awards.  It was also Editor’s Choice for Cloud Security Solutions in the 2017 Cyber Defense Magazine Awards. Dome9 just received $16.5 … Continue reading →

Posted in Science & Technology | Leave a comment

Keeping your computer healthy

Posted on August 2, 2015

Israeli startup Fixico has been chosen by IBM to export its remote Endpoint Management product to the private market. Now you can download Fixico to check your computer’s functions, disk and programs upon startup. Fixico has free basic features or … Continue reading →

Posted in Science & Technology | Leave a comment

Trial of new cancer antibody approved

Posted on January 18, 2015

Israel’s cCAM has received US FDA approval to commence trials of its CM-24 monoclonal antibody (mAb) for the treatment of various types of cancers.  CM-24 targets CEACAM1, a novel immune checkpoint protein expressed on a variety of cancer cells. http://finance.yahoo.com/news/ccam-biotherapeutics-receives-fda-approval-121500561.html

Posted in Israel's Medical Achievements | Leave a comment